ARTICLE | Clinical News
Pheburane sodium phenylbutyrate regulatory update
February 16, 2015 8:00 AM UTC
The Medunik Canada subsidiary of Le Groupe Pharmaceutique Boivin (Montreal, Quebec) said Health Canada approved Pheburane sodium phenylbutyrate as adjunctive therapy in the chronic management of urea...